South Africa’s treatment and prevention programs for HIV/AIDS are on a promising path, according to the country’s latest HIV household survey, released this week by the Human Sciences Research Council.

Proposed health reforms are moving South Africa toward universal health coverage, but these plans are largely steered toward clinical services. Still, the Public Health Medicine (PHM) specialty remains popular among South African physicians, who tend to pursue the 4-year…

Pollution is the deadliest environmental health hazard on the planet, yet South Africa remains the only sub-Saharan African country with an air-quality monitoring program. Researchers with the Eastern African GEOHealth hub are starting to fill that data gap. The…

“Are you drinking yourself sick?” South Africans were asked. The answer: A resounding yes. On Sunday, April 1, South Africa will become the first country in Africa to implement an excise tax on sugary drinks in an attempt to stem the country’s growing obesity and diabetes…

In many low- and middle-income countries with a heavy HIV burden, data is sorely lacking on underlying STIs that up the risk.

In Africa, the risk of dying from scheduled surgery is more than double the global average, reports a new study in The Lancet—considered a deep dive into a little-studied issue.

In South Africa, violence is an all-too-common part of the lives of the 20% of reproductive-age women who are HIV positive.   Their HIV-positive status can trigger violent reactions from their partner, according to some women who participated in University of the…

The same gender norms that promote violence against heterosexual women are at play when South African women are abused by female partners, according to a 2016 report by a Cape Town advocacy group.  

A new study out of Durban, South Africa, on a rare and deadly form of TB found that most victims had contracted the disease from close contact with another victim, not as a result of treatment failure.  

South Africa has launched its largest HIV vaccine trial yet, fueling hope among the many who believe it will take a vaccine to stop the virus despite treatment advances.   The vaccine in question, the RV144 combo, demonstrated a modest benefit of about 31% in a trial in…